[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Submit :: Contact Us ::
:: Volume 11, Issue 3 (Atumn 2021) ::
JABS 2021, 11(3): 3895-3902 Back to browse issues page
Association between COVID-19 and Gastrointestinal Manifestations and Available Treatment Options
Fatemeh Heiat1 , Ramin Hosseinzadeh2 , Mohammadali Abyazi3 , Reza Ranjbar4 , Ahmad Khonche3 , Mohammad Heiat 5
1- Department of Physical Education and Sport Sciences, Fasa Branch, Islamic Azad University, Fasa, Iran
2- Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3- Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran
4- Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
5- Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran , mohamad.heiat@gmail.com
Abstract:   (459 Views)
Background & Objective: Corona virus disease 2019 (COVID-19) is an emerging outbreak which has involved almost all of the countries of the world now. While the main symptoms of the disease are known to be respiratory symptoms like coughing and shortness of breath, extrapulmonary symptoms have also been reported in many cases of COVID-19. Gastrointestinal (GI) manifestations including diarrhea, nausea and vomiting, abdominal pain and liver injury are amongst the most common extrapulmonary symptoms in COVID-19 patients.
Materials & Method: We used Scopus, PubMed, and Google scholar databases for this review. The last search was run on November 21, 2020
Results: Liver injury is mostly accompanied by an elevation in AST and ALT levels and a slight increase in serum billirubin levels that is observed in approximately 14.8-53.1% of COVID-19 patients.1-29% of COVID-19 patients present nausea and vomiting and 2 to 10% develop diarrhea. Abdominal pain is seen in about 2.2-6% of COVID-19 patients and most frequently seen in severely ill patients.
Conclusion: Diarrhea, nausea, and vomiting and liver injury are the most common GI symptoms in COVID-19 patients while abdominal pain is not pretty common. There are no medications of proven efficacy to treat COVID-19 or its GI manifestations so far.
 

Keywords: COVID-19, gastrointestinal manifestations, treatment protocols, extra pulmonary
Full-Text [PDF 240 kb]   (62 Downloads)    
Type of Study: Review | Subject: Gastroenterology
Received: 2020/11/12 | Accepted: 2021/06/19 | Published: 2021/11/13
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Heiat F, Hosseinzadeh R, Abyazi M, Ranjbar R, Khonche A, Heiat M. Association between COVID-19 and Gastrointestinal Manifestations and Available Treatment Options. JABS. 2021; 11 (3) :3895-3902
URL: http://jabs.fums.ac.ir/article-1-2533-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 3 (Atumn 2021) Back to browse issues page
Journal of Fasa University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4343